{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:41:29Z","timestamp":1771634489652,"version":"3.50.1"},"reference-count":68,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>In the cerebral cortex, glutamate activates NMDA receptors (NMDARs), localized in noradrenergic neurons, inducing noradrenaline release that may have a permissive effect on glutamatergic transmission, and therefore, on the modulation of long-term plasticity. ATP is co-released with noradrenaline, and with its metabolites (ADP and adenosine) is involved in the purinergic modulation of electrically-evoked noradrenaline release. However, it is not known if noradrenaline release evoked by activation of NMDARs is also under purinergic modulation. The present study aimed to investigate and to characterize the purinergic modulation of noradrenaline release evoked by NMDARs. Stimulation of rat cortical slices with 30 \u00b5M NMDA increased noradrenaline release, which was inhibited by ATP upon metabolization into ADP and adenosine and by the selective agonists of A1 and A2A receptors, CPA and CGS2680, respectively. It was also inhibited by UTP and UDP, which are mainly released under pathophysiological situations. Characterization of the effects mediated by these compounds indicated the involvement of P2Y1, P2Y6, A1 and A2A receptors. It is concluded that, in the rat brain cortex, NMDA-evoked noradrenaline release is modulated by several purinergic receptors that may represent a relevant mechanism to regulate the permissive effect of noradrenaline on NMDA-induced neuroplasticity.<\/jats:p>","DOI":"10.3390\/cells12131690","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T01:54:56Z","timestamp":1687485296000},"page":"1690","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Involvement of P2Y1, P2Y6, A1 and A2A Receptors in the Purinergic Inhibition of NMDA-Evoked Noradrenaline Release in the Rat Brain Cortex"],"prefix":"10.3390","volume":"12","author":[{"given":"Clara","family":"Quintas","sequence":"first","affiliation":[{"name":"Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3045-2150","authenticated-orcid":false,"given":"Jorge","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"given":"Gl\u00f3ria","family":"Queiroz","sequence":"additional","affiliation":[{"name":"Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nn.3458","article-title":"Developmental origins of central norepinephrine neuron diversity","volume":"16","author":"Robertson","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"R1051","DOI":"10.1016\/j.cub.2015.09.039","article-title":"Organization of the locus coeruleus norepinephrine system","volume":"25","author":"Schwarz","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1152\/ajpregu.00556.2010","article-title":"Hindbrain noradrenergic A2 neurons: Diverse roles in autonomic, endocrine, cognitive, and behavioural functions","volume":"300","author":"Rinaman","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuron.2012.09.011","article-title":"Orienting and reorienting: The locus coeruleus mediates cognition through arousal","volume":"76","author":"Sara","year":"2012","journal-title":"Neuron"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41593-022-01102-9","article-title":"Memory-enhancing properties of sleep depend on the oscillatory amplitude of norepinephrine","volume":"25","author":"Kjaerby","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1038\/s41467-022-35342-x","article-title":"Noradrenergic signaling mediates cortical early tagging and storage of remote memory","volume":"13","author":"Fan","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.brainres.2016.01.033","article-title":"Layer- and area-specific actions of norepinephrine on cortical synaptic transmission","volume":"1641","author":"Salgado","year":"2016","journal-title":"Brain Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1073858408322675","article-title":"Presynaptic NMDA Receptors: Newly Appreciated Roles in Cortical Synaptic Function and Plasticity","volume":"14","author":"Corlew","year":"2008","journal-title":"Neuroscientist"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1017\/S0140525X15000667","article-title":"Norepinephrine ignites local hotspots of neuronal excitation: How arousal amplifies selectivity in perception and memory","volume":"39","author":"Mather","year":"2016","journal-title":"Behav. Brain Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1084\/jem.20161673","article-title":"Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations","volume":"214","author":"Bading","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/bph.15349","article-title":"Presynaptic release-regulating NMDA receptors in isolated nerve terminals: A narrative review","volume":"178","author":"Pittaluga","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/BF00167254","article-title":"N-methyl-D-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: Receptor location, characterization and desensitization","volume":"339","author":"Fink","year":"1989","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0014-2999(90)90219-V","article-title":"Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex","volume":"185","author":"Fink","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1471-4159.1992.tb09297.x","article-title":"Presynaptic glutamate receptors regulate noradrenaline release from isolated nerve terminals","volume":"58","author":"Wang","year":"1992","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0306-4522(00)00529-7","article-title":"Co-transmitter function of ATP in central catecholamininergic neurons of the rat","volume":"102","author":"Poelchen","year":"2001","journal-title":"Neuroscience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1476-5381.1994.tb17066.x","article-title":"Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex","volume":"113","author":"Kurz","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1152\/jn.00708.2012","article-title":"Purinergic modulation of norepinephrine release and uptake in rat brain cortex: Contribution of glial cells","volume":"110","author":"Pinho","year":"2013","journal-title":"J. Neurophysiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1023\/A:1012388618693","article-title":"Purinergic Signalling: ATP Release","volume":"26","author":"Bodin","year":"2001","journal-title":"Neurochem. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of Adenosine Receptors: The State of the Art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y receptor pharmacology: IUPHAR Review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR Review 30","volume":"178","author":"Illes","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6031478","DOI":"10.1155\/2017\/6031478","article-title":"Noradrenergic Modulation of Cognition in Health and Disease","volume":"2017","author":"Borodovitsyna","year":"2017","journal-title":"Neural Plast."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"113179","DOI":"10.1016\/j.biopha.2022.113179","article-title":"Locus Coeruleus\u2014Noradrenaline system: Looking into Alzheimer\u2019s therapeutics with rose-coloured glasses","volume":"151","author":"Behl","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S1092852900016734","article-title":"Inflammation, glutamate, and glia in depression: A literature review","volume":"13","author":"McNally","year":"2008","journal-title":"CNS Spectr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fphar.2018.00193","article-title":"The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy","volume":"9","author":"Alves","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jnc.15007","article-title":"A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer brain","volume":"154","author":"Li","year":"2020","journal-title":"J. Neurochem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Adell, A. (2020). Brain NMDA Receptors in Schizophrenia and Depression. Biomolecules, 10.","DOI":"10.3390\/biom10060947"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.brainresbull.2019.03.010","article-title":"Pharmacology of P2Y receptors","volume":"151","year":"2019","journal-title":"Brain Res. Bull."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/978-3-540-74805-2_11","article-title":"Presynaptic Adenosine and P2Y receptors: Pharmacology of neurotransmitter release","volume":"184","author":"Queiroz","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.bjp.0703234","article-title":"Inhibition by adenosine A2A receptors of NMDA but not AMPA currents in rat neostriatal neurons","volume":"130","author":"Wirkner","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(91)90831-A","article-title":"Inhibitory effects of NMDA receptor antagonists on hypoxia-induced seizures in dietary Mg2+-deficient mice","volume":"204","author":"Nakanishi","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1476-5381.1982.tb08758.x","article-title":"The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations","volume":"75","author":"Evans","year":"1982","journal-title":"Br. J. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.2154034","article-title":"2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia","volume":"247","author":"Sheardown","year":"1990","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0896-6273(92)90119-X","article-title":"Slow voltage-dependent changes in channel open-state probability underlie hysteresis of NMDA responses in Mg2+ free solutions","volume":"8","author":"Nowak","year":"1992","journal-title":"Neuron"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbamcr.2008.09.014","article-title":"A membrane network of receptors and enzymes for adenine nucleotides and nucleosides","volume":"1793","author":"Schicker","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7742(05)63007-3","article-title":"Adenosine and brain function","volume":"63","author":"Fredholm","year":"2005","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1523\/JNEUROSCI.0628-05.2005","article-title":"Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2\/3, and P2X3 and inhibitory P2Y1, P2Y2, and\/or P2Y4 receptors in the rat hippocampus","volume":"25","author":"Rodrigues","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/978-3-540-74805-2_15","article-title":"Presynaptic lonotropic receptors. Pharmacology of neurotransmitter release","volume":"184","author":"Dorostkar","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/jpet.105.094037","article-title":"MRS 2500 [2-iodo-N6-methyl-(N)-methano-carba-2\u2019-deoxyadenosine-3\u2019,5\u2019-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice","volume":"316","author":"Hechler","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/jm981072s","article-title":"Antagonists of the platelet P2T receptor: A novel approach to antithrombotic therapy","volume":"42","author":"Ingall","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11302-008-9106-2","article-title":"Development of selective agonists and antagonists of P2Y receptors","volume":"5","author":"Jacobson","year":"2009","journal-title":"Purinergic Signal."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1471-4159.2008.05391.x","article-title":"P2Y receptor mediated inhibitory modulation of noradrenaline release in response to electrical field stimulation and ischemic conditions in superfused rat hippocampus slices","volume":"106","author":"Heinrich","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuropharm.2007.10.013","article-title":"Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord","volume":"54","author":"Heinrich","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0197-0186(02)00069-4","article-title":"P2Y1 receptor activation inhibits NMDA receptor-channels in layer V pyramidal neurons of the rat prefrontal and parietal cortex","volume":"42","author":"Luthardt","year":"2003","journal-title":"Neurochem. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.bcp.2004.01.011","article-title":"Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors","volume":"67","author":"Mamedova","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bjp.0705242","article-title":"P2Y receptor regulation of cultured rat cerebral cortical cells: Calcium responses and mRNA expression in neurons and glia","volume":"139","author":"Bennett","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainresrev.2004.12.004","article-title":"Pathophysiological roles of extracellular nucleotides in glial cells: Differential expression of purinergic receptors in resting and activated microglia","volume":"48","author":"Bianco","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tins.2008.11.003","article-title":"Purinergic signalling in inflammation of the central nervous system","volume":"32","author":"Ceruti","year":"2009","journal-title":"Trends Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.tins.2008.10.001","article-title":"Purinergic signalling in the nervous system: An overview","volume":"32","author":"Abbracchio","year":"2009","journal-title":"Trends Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bcp.2007.12.009","article-title":"Uracil nucleotides: From metabolic intermediates to neuroprotection and neuroinflammation","volume":"75","author":"Lecca","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00165806","article-title":"8-Cyclopentyl-1,3-dipropylxanthine (DPCPX)- a selective high affinity antagonist radioligand for A1 adenosine receptors","volume":"336","author":"Lohse","year":"1987","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/jm00148a001","article-title":"N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists","volume":"28","author":"Moos","year":"1985","journal-title":"J. Med. Chem."},{"key":"ref_56","first-page":"398","article-title":"The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2A adenosine receptor antagonist","volume":"276","author":"Zocchi","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_57","first-page":"47","article-title":"CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity","volume":"251","author":"Hutchison","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0165-6147(00)01517-0","article-title":"Fine-tuning neuromodulation by adenosine","volume":"21","author":"Ribeiro","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01345239","article-title":"Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons","volume":"14","author":"Wirkner","year":"1998","journal-title":"Amino Acids"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1471-4159.2006.03651.x","article-title":"Protein kinase C enhances glycine-insensitive desensitization of NMDA receptors independently of previously identified protein kinase C sites","volume":"96","author":"Jackson","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"855752","DOI":"10.3389\/fnmol.2022.855752","article-title":"Role of Ca2+\/Calmodulin-Dependent Protein Kinase Type II in Mediating Function and Dysfunction at Glutamatergic Synapses","volume":"15","author":"Mohanan","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1476-5381.2009.00624.x","article-title":"Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment","volume":"160","author":"Vizi","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"267120","DOI":"10.1100\/2012\/267120","article-title":"Distribution of Extrasynaptic NMDA Receptors on Neurons","volume":"2012","author":"Petralia","year":"2012","journal-title":"Sci. World J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"20130601","DOI":"10.1098\/rstb.2013.0601","article-title":"Organization, control and function of extrasynaptic NMDA receptors","volume":"369","author":"Papouin","year":"2014","journal-title":"Philos. Trans. R. Soc. B"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2018.12.012","article-title":"P2 receptor interaction and signalling cascades in neuroprotection","volume":"151","author":"Queipo","year":"2019","journal-title":"Brain Res. Bull."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00018-018-2837-5","article-title":"Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability","volume":"75","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-021-01153-2","article-title":"Chronically altered NMDAR signaling in epilepsy mediates comorbid Depression","volume":"9","author":"Sadeghi","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"113125","DOI":"10.1016\/j.biopha.2022.113125","article-title":"Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke","volume":"151","author":"Shen","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/13\/1690\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:58:38Z","timestamp":1760126318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/13\/1690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":68,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["cells12131690"],"URL":"https:\/\/doi.org\/10.3390\/cells12131690","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}